The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 19, 2013
Filed:
Dec. 17, 2008
Daniel Rees Allen, Saffron Walden, GB;
George Martin Buckley, Slough, GB;
Roland Bürli, Saffron Walden, GB;
John Richard Davenport, Slough, GB;
Natasha Kinsella, Slough, GB;
Christopher James Lock, Slough, GB;
Christopher Lowe, Slough, GB;
Stephen Robert Mack, Slough, GB;
William Ross Pitt, Slough, GB;
Andrew James Ratcliffe, Slough, GB;
Marianna Dilani Richard, Slough, GB;
Verity Margaret Sabin, Slough, GB;
Andrew Sharpe, Saffron Walden, GB;
Laura Jane Tait, Slough, GB;
Graham John Warrellow, Slough, GB;
Sophie Caroline Williams, Slough, GB;
Daniel Rees Allen, Saffron Walden, GB;
George Martin Buckley, Slough, GB;
Roland Bürli, Saffron Walden, GB;
John Richard Davenport, Slough, GB;
Natasha Kinsella, Slough, GB;
Christopher James Lock, Slough, GB;
Christopher Lowe, Slough, GB;
Stephen Robert Mack, Slough, GB;
William Ross Pitt, Slough, GB;
Andrew James Ratcliffe, Slough, GB;
Marianna Dilani Richard, Slough, GB;
Verity Margaret Sabin, Slough, GB;
Andrew Sharpe, Saffron Walden, GB;
Laura Jane Tait, Slough, GB;
Graham John Warrellow, Slough, GB;
Sophie Caroline Williams, Slough, GB;
UCB Pharma S.A., Brussels, BE;
Abstract
A series of heteroaryl-substituted quinoxaline and quinoline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions, said substituted derivatives having the general formula